IRCT20220111053692N16招募中Unknown
Bioequivalence study of Gliclazide 80 mg Tablet (Tehran Chemie) versus Diamicron (SERVIER) Tablet after single oral dosing in healthy volunteers
Tehran Chemie Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- Male
入选标准
- •18 to 55 years old.
- •Weight in range of 10 % proper body weight.
- •All volunteers should be in a good health condition on the basis of medical history, physical examination, routine blood test.
- •Possessing negative test for hepatitis B surface antigen (HBs-Ag), Antihepatitis-C antibody (anti-HCV) and anti-HIV.
- •just the man
排除标准
- •Volunteers with hypersensitivity to Gliclazide were excluded.
- •Those with known history of drug abuse. alcohol consumer or cigarette smokers.
- •Taking medications that have drug interactions with Gliclazide until one month before studying.
- •Disinclination to take the test.
- •Blood donation or blood loss of more than 200 ml in the past month.
研究者
相似试验
已完成
1 期
Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet FormulationsHealthyNCT02643329Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited17
已完成
Unknown
Bioequivalence study of Gliclazide 30 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersBioequivalence study of Gliclazide 30 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N9Aria Sepahan Pharmaceutical Co24
已完成
Unknown
Bioequivalence study of Gliclazide 30 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersBioequivalence study of Gliclazide 30 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N10Tehran Chemie Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of Gliclazide 60 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersIRCT20220111053692N7Tehran Chemie Pharmaceutical Company24
已完成
不适用
Bioequivalence study of Gliclazide 60 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersIRCT20220111053692N6Aria Sepahan Pharmaceutical Co24